SciSparc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SciSparc and other ETFs, options, and stocks.About SPRC
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs.
CEOOz Adler
CEOOz Adler
Employees2
Employees2
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2004
Founded2004
Employees2
Employees2
SPRC Key Statistics
Market cap1.30M
Market cap1.30M
Price-Earnings ratio-1.25
Price-Earnings ratio-1.25
Dividend yield—
Dividend yield—
Average volume1.86M
Average volume1.86M
High today$2.67
High today$2.67
Low today$2.34
Low today$2.34
Open price$2.44
Open price$2.44
Volume294.12K
Volume294.12K
52 Week high$37.59
52 Week high$37.59
52 Week low$2.33
52 Week low$2.33
SPRC News
TipRanks 4d
SciSparc Ltd. Converts Debentures into Equity, Issuing New SharesElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 5d
SciSparc says AutoMax shareholders approve mergerSciSparc (SPRC)announced that AutoMax Motors convened its special general meetings, at which, among others, AutoMax’s shareholders voted on and approved the pro...
People also own
Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.